Scott Alderucci

Director of Process Development Curia Global, Inc.

Seminars

Wednesday 22nd July 2026
Manufacturing Decisions That Shape mRNA Clinical Success
12:10 pm
  • Confusing your platform with solid ground can lead to clinical stumbles
  • Yield that ignores RNA integrity or impurity directly reduce potency or increase reactogenicity
  • Capping efficiency and the Poly-A tail are clinical levers, not just a spec
Scott Alderucci